Navigation Links
Dr. Daniel Ronel Offers New Permanent Lip Enhancement in New Mexico

One of the most popular aesthetic procedures is lip enhancement. 'The lips are the first thing that most people notice about women' explains Dr. Daniel Ronel, a board certified plastic surgeon in Albuquerque and Santa Fe New Mexico.

(Vocus) May 21, 2009 -- One of the most popular aesthetic procedures is lip enhancement. 'The lips are the first thing that most people notice about women' explains Dr. Daniel Ronel, a board certified plastic surgeon in Albuquerque and Santa Fe New Mexico. 'The cosmetic industry recognizes that women spend billions of dollars on their lips, from lipstick to aesthetic injectables." Most augment their lips with injectable fillers, which are repeated about once a year or even more often. Now there is a safe, permanent solution: PermaLip.
The lip implant is made of soft silicone gel, like a "gummy bear" candy. An excellent alternative to repetitive, costly, and painful filler injections, the PermaLip has undergone extensive clinical testing to ensure its safety and efficacy. The procedure is performed in a simple in office visit that only takes 30 - 40 minutes. It does not have the problems associated with earlier generations of implants, and it is easily removed if desired.
Dr. Ronel explains, 'It is a vast improvement over injectable fillers. The implant gives me the ability to enhance the lips in a way that doesn't change over time. It is safe and soft. I highly recommend it for anyone considering lip enhancement, since the results are terrific.'
And what about kissing? Is there a way someone will be able to tell whether or not someone has lip implants? Nelda Jimenez, one of Dr. Ronel's patients in Albuquerque says 'it's virtually impossible to tell, in fact, my husband says that he can't tell I even got them!'

DR. DANIEL RONEL is a board-certified plastic surgeon with offices in Santa Fe and Albuquerque NM. Educated and trained at Princeton, Penn, Columbia, Cornell, and Harvard, he is the only surgeon in the US who is board certified in both plastic surgery and pediatrics. Dr. Ronel was named one of America's Top Plastic Surgeons by the Consumer's Research Council of America. Because of his combined expertise in pediatrics and plastic surgery, Dr. Ronel is one of 13 national experts selected by Allergan to sit on the Breast Implant Research Team, an advisory panel on silicone breast implants. Additionally, Dr. Ronel is a member of the Radiesse Medical Education Facility, a group composed of approximately 120 physicians from across the United States who are experts in the field of injectable fillers. He was voted Albuquerque's Plastic Surgeon of the Year in 2007 by readers of The Herald, and was named one of Albuquerque's 2007 Top Docs by Albuquerque, the Magazine



Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
2. Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards
3. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
4. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
5. Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
6. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
7. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
8. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
9. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
10. Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
11. SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: